BeOne Medicines Q3 revenue rises 34%, lifts 2026 outlook
BeOne Medicines reported a 34% rise in Q3 revenue and lifted its 2026 outlook.
Story updates
11:13:04 AM UTC
SquawkNews
BEONE MEDICINES: RAISED 2026 TOTAL REVENUE GUIDANCE TO $6.9 BLN TO $7.0 BLN